RGNX Trial readout: Wednesday, October 28, 2026
CompanyREGENXBIO Inc. (RGNX)
EventTrial readout
Date~ Wednesday, October 28, 2026 (estimated month)
MarketUS listing
SourceCT.gov registry · confidence 70% · primary source ↗
Est. Completion: 2026-10. Status: ACTIVE_NOT_RECRUITING. Title: Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.